The purpose of this study is to evaluate the effect of dexmedetomidine on hemodynamic responses during laryngoscopy and double lumen endotracheal intubation and assess the adverse effect related to complications of dexmedetomidine.
The cardiovascular responses to laryngoscopy and tracheal intubation are mediated by both sympathetic and parasympathetic nervous system. The hemodynamic responses resulting from sympathetic nervous system stimulation are tachycardia, cardiac arrhythmias, hypertension, increased intraocular pressure, increased intracranial pressure, bronchospasm and myocardial ischemia. Tachycardia is one of the major predictor of intraoperative myocardial ischemia and causes an imbalance of myocardial oxygen supply and demand. Although hemodynamic responses to laryngoscopy and intubation is transient, these effect may be harmful to patients suffering from myocardial and cerebrovascular diseases. The placement of double lumen endotracheal tube may produce similar or greater pressor response than endotracheal tube because of larger sizes and greater carinal stimulation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
60
dexmedetomidine 0.7 microgram per kilogram in saline 20 ml given within 10 minutes before intubation
normal saline 20 ml( the same volume as dexmedetomidine) giving within 10 minutes.
Chiang Mai University Hospital
Maung, Chiang Mai, Thailand
change in systolic blood pressure
direct arterial pressure monitoring
Time frame: (day 1) before induction, before intubation and every minute for the first 10 minutes after endotracheal intubation
change in diastolic blood pressure
direct arterial pressure monitoring
Time frame: (day 1) before induction, before intubation and every minute for the first 10 minutes after endotracheal intubation
change in mean arterial pressure
direct arterial pressure monitoring
Time frame: (day 1) before induction, before intubation and every minute for the first 10 minutes after endotracheal intubation
change in heart rate
Time frame: (day 1) before induction, before intubation and every minute for the first 10 minutes after endotracheal intubation
adverse events related to dexmedetomidine
bradycardia, hypotension, arrhythmia
Time frame: (day 1) during dexmedetomidine administration until 10 minutes after endotracheal intubation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.